Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy. | Blood Adv | 2024 | 38019014 | PubTator, text mining | PubMed |
| Combination of eriocalyxin B and homoharringtonine exerts synergistic anti-tumor effects against t(8;21) AML. | Acta Pharmacol Sin | 2024 | 38017299 | PubTator, text mining | PubMed |
| Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia Using Flow Cytometry. | Mod Pathol | 2024 | 37925056 | PubTator, text mining | PubMed |
| FusionNeoAntigen: a resource of fusion gene-specific neoantigens. | Nucleic Acids Res | 2024 | 37870454 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing of a new transgenic t(8;21) preleukemia mouse model reveals regulatory networks promoting leukemic transformation. | Leukemia | 2024 | 37838757 | PubTator, text mining | PubMed |
| Signaling pathways governing the behaviors of leukemia stem cells. | Genes Dis | 2024 | 37692500 | PubTator, text mining | PubMed |
| Safety of ovarian cryopreservation and transplantation in patients with acute leukemia: a case series. | Am J Obstet Gynecol | 2024 | 37666382 | PubTator, text mining | PubMed |
| The essential roles of m6A modification in osteogenesis and common bone diseases. | Genes Dis | 2024 | 37588215 | PubTator, text mining | PubMed |
| Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia. | Haematologica | 2024 | 37345475 | PubTator, text mining | PubMed |
| Clinico-Hematological Profile of Acute Myeloid Leukemia: Experience From a Tertiary Care Cancer Center in North India. | Cureus | 2023 | 38249207 | PubTator, text mining | PubMed |
| Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer. | Curr Oncol | 2023 | 38248100 | PubTator, text mining | PubMed |
| miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities. | Cells | 2023 | 38201290 | PubTator, text mining | PubMed |
| Deciphering Acute Myeloid Leukemia Associated Transcription Factors in Human Primary CD34+ Hematopoietic Stem/Progenitor Cells. | Cells | 2023 | 38201282 | PubTator, text mining | PubMed |
| [Efficacy analysis of selinexor combined with hypomethylating agent in the treatment of refractory/relapsed acute myeloid leukemia exposed to venetoclax]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38185524 | PubTator, text mining | PubMed |
| Long-term survival in a patient with primary refractory AML after salvage allogeneic hematopoietic transplantation and post-transplant localized irradiation and venetoclax maintenance: a case report. | Front Oncol | 2023 | 38162505 | PubTator, text mining | PubMed |
| RENGE infers gene regulatory networks using time-series single-cell RNA-seq data with CRISPR perturbations. | Commun Biol | 2023 | 38155269 | PubTator, text mining | PubMed |
| Aberrant myelomonocytic CD56 expression predicts response to cyclosporine therapy in pediatric patients with moderate aplastic anemia. | Front Pediatr | 2023 | 38152649 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T Cell Therapy for Acute Leukemia. | Blood Cell Ther | 2023 | 38149027 | PubTator, text mining | PubMed |
| Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia. | Commun Biol | 2023 | 38129572 | PubTator, text mining | PubMed |
| Role of the immune system in liver transplantation and its implications for therapeutic interventions. | MedComm (2020) | 2023 | 38098611 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=8